Schizophrenia Research
Volume 98, Issue 1 , Pages 98-104 , January 2008

No association between the DRD3 Ser9Gly polymorphism and schizophrenia

  • Ferid Fathalli

      Affiliations

    • Douglas Hospital Research Centre, Montréal, Québec, Canada
    • Montréal University, Montréal, Québec, Canada
    • ,
  • Guy A. Rouleau

      Affiliations

    • Montréal University, Montréal, Québec, Canada
    • Notre Dame Hospital Research Centre (CHUM), Montréal, Québec, Canada
    • ,
  • Lan Xiong

      Affiliations

    • Notre Dame Hospital Research Centre (CHUM), Montréal, Québec, Canada
    • ,
  • Karim Tabbane

      Affiliations

    • Department of Psychiatry, University of Tunis, Tunisia
    • ,
  • Chawki Benkelfat

      Affiliations

    • Department of Psychiatry, McGill University, Montréal, Québec, Canada
    • ,
  • Rosherrie Deguzman

      Affiliations

    • Douglas Hospital Research Centre, Montréal, Québec, Canada
    • ,
  • Danics Zoltan

      Affiliations

    • National Institute of Psychiatry, Budapest, Hungary
    • ,
  • Samarthji Lal

      Affiliations

    • Douglas Hospital Research Centre, Montréal, Québec, Canada
    • Department of Psychiatry, McGill University, Montréal, Québec, Canada
    • ,
  • Sarogini D’cruz

      Affiliations

    • Douglas Hospital Research Centre, Montréal, Québec, Canada
    • ,
  • Ridha Joober

      Affiliations

    • Douglas Hospital Research Centre, Montréal, Québec, Canada
    • Department of Psychiatry, McGill University, Montréal, Québec, Canada
    • Corresponding Author InformationCorresponding author. Douglas Hospital Research Center 6875, Boul LaSalle Verdun, Quebec, Canada H4H 1R3; Department of Psychiatry, McGill University, Montréal, Québec, Canada. Tel.: +1 514 762 3048; fax: +1 514 888 4064.

Received 11 January 2007 ,Revised 1 July 2007 ,Accepted 4 July 2007.

References 

  1. Asherson P, Mant R, Holmans P, Williams J, Cardno A, Murphy K, et al. Linkage, association and mutational analysis of the dopamine D3 receptor gene in schizophrenia. Mol. Psychiatry. 1996;1:125–132
  2. Basile VS, Masellis M, Badri F, Paterson AD, Meltzer HY, Lieberman JA, et al. Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia. Neuropsychopharmacology. 1999;21:17–27
  3. Bogerts B. The neuropathology of schizophrenic disease: historical aspects and present knowledge. Eur. Arch. Psychiatry Clin. Neurosci. 1999;249:2–13
  4. Cannon M, Murray RM. Neonatal origins of schizophrenia. Arch. Dis. Child. 1998;78:1–3
  5. Carlsson A, Lindqvist M. Effect of chlorpromazine or haloperidol on formation of 3 methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol. Toxicol. (Copenh). 1963;20:140–144
  6. Chen CH, Liu MY, Wei FC, Koong FJ, Hwu HG, Hsiao KJ. Further evidence of no association between Ser9Gly polymorphism of dopamine D3 receptor gene and schizophrenia. Am. J. Med. Genet. 1997;74:40–43
  7. Chong SA, Tan EC, Tan CH, Mythily , Chan YH. Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003;116:51–54
  8. Crocq MA, Mant R, Asherson P, Williams J, Hode Y, Mayerova A, et al. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J. Med. Genet. 1992;29:858–860
  9. Dahmen N, Muller M, Germeyer S, Rujescu D, Anghelescu I, Hiemke C, et al. Genetic polymorphisms of the dopamine 2 and D3 receptor and neuroleptic drug effects in schizophrenic patients. Schizophr. Res. 2001;49:223–225
  10. Di Bella D, Catalano M, Strukel A, Nobile M, Novelli E, Smeraldi E. Distribution of the MscI polymorphism of the dopamine D3 receptor in an Italian psychotic population. Psychiatr. Genet. 1994;4:39–42
  11. Dubertret C, Gorwood P, Ades J, Feingold J, Schwartz JC, Sokoloff P. Meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in Caucasians. Am. J. Med. Genet. 1998;81:318–322
  12. Durany N, Thome J, Palomo A, Foley P, Riederer P, Cruz-Sanchez FF. Homozygosity at the dopamine D3 receptor gene in schizophrenic patients. Neurosci. Lett. 1996;220:151–154
  13. Ebstein RP, Macciardi F, Heresco-Levi U, Serretti A, Blaine D, Verga M, et al. Evidence for an association between the dopamine D3 receptor gene DRD3 and schizophrenia. Hum. Hered. 1997;47:6–16
  14. Elvidge G, Jones I, McCandless F, Asherson P, Owen MJ, Craddock N. Allelic variation of a BalI polymorphism in the DRD3 gene does not influence susceptibility to bipolar disorder: results of analysis and meta-analysis. Am. J. Med. Genet. 2001;105:307–311
  15. Gaitonde EJ, Morris A, Sivagnanasundaram S, McKenna PJ, Hunt DM, Mollon JD. Assessment of association of D3 dopamine receptor MscI polymorphism with schizophrenia: analysis of symptom ratings, family history, age at onset, and movement disorders. Am. J. Med. Genet. 1996;67:455–458
  16. Giros B. Third dopamine receptor. A new target of action of neuroleptics. Pathol. Biol. (Paris). 1991;39:252–254
  17. Hawi Z, McCabe U, Straub RE, O'Neill A, Kendler KS, Walsh D, et al. Examination of new and reported data of the DRD3/MscI polymorphism: no support for the proposed association with schizophrenia. Mol. Psychiatry. 1998;3:150–155
  18. Horvath S, Xu X, Laird NM. The family based association test method: strategies for studying general genotype–phenotype associations. Eur. J. Hum. Genet. 2001;9:301–306
  19. Jonsson E, Lannfelt L, Sokoloff P, Schwartz JC, Sedvall G. Lack of association between schizophrenia and alleles in the dopamine D3 receptor gene. Acta Psychiatr. Scand. 1993;87:345–349
  20. Jonsson EG, Flyckt L, Burgert E, Crocq MA, Forslund K, Mattila-Evenden M, et al. Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Psychiatr. Genet. 2003;13:1–12
  21. Jonsson EG, Kaiser R, Brockmoller J, Nimgaonkar VL, Crocq MA. Meta-analysis of the dopamine D3 receptor gene (DRD3) Ser9Gly variant and schizophrenia. Psychiatr. Genet. 2004;14:9–12
  22. Joober R, Toulouse A, Benkelfat C, Lal S, Bloom D, Labelle A, et al. DRD3 and DAT1 genes in schizophrenia: an association study. J. Psychiatr. Res. 2000;34:285–291
  23. Kendler KS, Diehl SR. The genetics of schizophrenia: a current, genetic–epidemiologic perspective. Schizophr. Bull. 1993;19:261–285
  24. Kennedy JL, Billett EA, Macciardi FM, Verga M, Parsons TJ, Meltzer HY, et al. Association study of dopamine D3 receptor gene and schizophrenia. Am. J. Med. Genet. 1995;60:558–562
  25. Kendler KS. Psychiatric genetics: a methodologic critique. Am. J. Psychiatry. 2005;162:3–11
  26. Krebs MO, Guillin O, Bourdell MC, Schwartz JC, Olie JP, Poirier MF, et al. Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia. Mol. Psychiatry. 2000;5:558–562
  27. Kremer I, Rietschel M, Dobrusin M, Mujaheed M, Murad I, Blanaru M, et al. No association between the dopamine D3 receptor Bal I polymorphism and schizophrenia in a family-based study of a Palestinian Arab population. Am. J. Med. Genet. 2000;96:778–780
  28. Lannfelt L, Sokoloff P, Martres MP, Pilon C, Giros B, Johnsson E, et al. Amino acid substitution in the dopamine D3 receptor as useful polymorphism for investigating psychiatric disorders. Psychiatr. Genet. 1992;2:249–256
  29. Laurent C, Savoye C, Samolyk D, Meloni R, Mallet J, Campion D, et al. Homozygosity at the dopamine D3 receptor locus is not associated with schizophrenia. J. Med. Genet. 1994;31:260
  30. Le Coniat M, Sokoloff P, Hillion J, Martres MP, Giros B, Pilon C, et al. Chromosomal localization of the human D3 dopamine receptor gene. Hum. Genet. 1991;85:618–620
  31. Le Foll B, Goldberg S, Sokoloff P. The dopamine D(3) receptor and drug dependence: effects on reward or beyond?. Neuropharmacology. 2005;49:525–541
  32. Lovlie R, Thara R, Padmavathi R, Steen V, McCreadie R. Ser9Gly dopamine D3 receptor polymorphism and spontaneous dyskinesia in never-medicated schizophrenic patients. Mol. Psychiatry. 2001;6:6–7
  33. Macciardi F, Verga M, Kennedy JL, Petronis A, Bersani G, Pancheri P, et al. An association study between schizophrenia and the dopamine receptor genes DRD3 and DRD4 using haplotype relative risk. Hum. Hered. 1994;44:328–336
  34. Mant R, Williams J, Asherson P, Parfitt E, McGuffin P, Owen MJ. Relationship between homozygosity at the dopamine D3 receptor gene and schizophrenia. Am. J. Med. Genet. 1994;54:21–26
  35. Hoogendoorn Mechteld LC, Bakker Steven C, Schnack Hugo G, Selten Jean-Paul C, Otten Henny G, Verduijn Willem, et al. No association between 12 dopaminergic genes and schizophrenia in a large Dutch sample. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005;134B:6–9
  36. Nimgaonkar VL, Sanders AR, Ganguli R, Zhang XR, Brar J, Hogge W, et al. Association study of schizophrenia and the dopamine D3 receptor gene locus in two independent samples. Am. J. Med. Genet. 1996;67:505–514
  37. Nothen MM, Cichon S, Propping P, Fimmers R, Schwab SG, Wildenauer DB. Excess of homozygosity at the dopamine D3 receptor gene in schizophrenia not confirmed. J. Med. Genet. 1993;30:708
  38. Owen MJ, McGuffin P. Association and linkage: complementary strategies for complex disorders. J. Med. Genet. 1993;30:638–639
  39. Perala J, Suvisaari J, Saarni SI, Kuoppasalmi K, Isometsa E, Pirkola S, et al. Lifetime prevalence of psychotic and bipolar i disorders in a general population. Arch. Gen. Psychiatry. 2007;64:19–28
  40. Prasad S, Deshpande SN, Bhatia T, Wood J, Nimgaonkar VL, Thelma BK. Association study of schizophrenia among Indian families. Am. J. Med. Genet. 1999;88:298–300
  41. Rabinowitz D, Laird N. A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum. Hered. 2000;50:211–223
  42. Rietschel M, Nothen MM, Albus M, Maier W, Minges J, Bondy B, et al. Dopamine D3 receptor Gly9/Ser9 polymorphism and schizophrenia: no increased frequency of homozygosity in German familial cases. Schizophr. Res. 1996;20:181–186
  43. Rothschild LG, Badner J, Cravchik A, Gershon ES, Gejman PV. No association detected between a D3 receptor gene-expressed variant and schizophrenia. Am. J. Med. Genet. 1996;67:232–234
  44. Sabate O, Campion D, d'Amato T, Martres MP, Sokoloff P, Giros B, et al. Failure to find evidence for linkage or association between the dopamine D3 receptor gene and schizophrenia. Am. J. Psychiatry. 1994;151:107–111
  45. Seeman P, Lee T, Chau-Wong M, Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature. 1976;261:717–719
  46. Serretti A, Lattuada E, Cusin C, Lilli R, Lorenzi C, Smeraldi E. Dopamine D3 receptor gene not associated with symptomatology of major psychoses. Am. J. Med. Genet. 1999;88:476–480
  47. Shaikh S, Collier D, Sham P, Ball D, Aitchison K, Vallada H, et al. Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia. Hum. Genet. 1996;97:714–719
  48. Snyder SH. Amphetamine psychosis: a “model” schizophrenia mediated by catecholamines. Am. J. Psychiatry. 1973;130:61–67
  49. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 1990;347:146–151
  50. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 1993;52:506–516
  51. Spurlock G, Williams J, McGuffin P, Aschauer HN, Lenzinger E, Fuchs K, et al. European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms. Am. J. Med. Genet. 1998;81:24–28
  52. Staddon S, Arranz MJ, Mancama D, Perez-Nievas F, Arrizabalaga I, Anney R, et al. Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate population. Schizophr. Res. 2005;73:49–54
  53. Steen VM, Lovlie R, MacEwan T, McCreadie RG. Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients. Mol. Psychiatry. 1997;2:139–145
  54. Szekeres G, Keri S, Juhasz A, Rimanoczy A, Szendi I, Czimmer C, et al. Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004;124:1–5
  55. Talkowski ME, Mansour H, Chowdari KV, Wood J, Butler A, Varna PG, et al. Novel, replicated associations between dopamine D3 receptor gene polymorphisms and schizophrenia in two indepedent sapmles. Biol. Psychiatry. 2006;60:570–577
  56. Tanaka T, Igarashi S, Onodera O, Tanaka H, Takahashi M, Maeda M, et al. Association study between schizophrenia and dopamine D3 receptor gene polymorphism. Am. J. Med. Genet. 1996;67:366–368
  57. Tiao-Lai H, Chien-Te L. Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients. J. Psychiatr. Res. 2005;40:664–668
  58. Tsuang MT, Lyons MJ, Faraone SV. Heterogeneity of schizophrenia. Conceptual models and analytic strategies. Br. J. Psychiatry. 1990;156:17–26
  59. Wiese C, Lannfelt L, Kristbjarnarson H, Yang L, Zoega T, Sokoloff P, et al. No evidence of linkage between schizophrenia and D3 dopamine receptor gene locus in Icelandic pedigrees. Psychiatry Res. 1993;46:69–78
  60. Williams J, Spurlock G, Holmans P, Mant R, Murphy K, Jones L, et al A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia. Mol. Psychiatry. 1998;3:141–149
  61. Wong AH, Buckle CE, VanTol HH. Polymorphisms in dopamine receptors: what do they tell us?. Eur. J. Pharmacol. 2000;410:183–203
  62. Yang L, Li T, Wiese C, Lannfelt L, Sokoloff P, Xu CT, et al. No association between schizophrenia and homozygosity at the D3 dopamine receptor gene. Am. J. Med. Genet. 1993;48:83–86
  63. Zhang ZJ, Zhang XB, Hou G, Yao H, Reynolds GP. Interaction between polymorphisms of the dopamine D3 receptor and manganese superoxide dismutase genes in susceptibility to tardive dyskinesia. Psychiatr. Genet. 2003;13:187–192

PII: S0920-9964(07)00300-3

doi: 10.1016/j.schres.2007.07.002

Schizophrenia Research
Volume 98, Issue 1 , Pages 98-104 , January 2008

Article Tools